CompuGroup Medical SE & Co. KGaA (COP.DE)
EUR 22.04
(-0.27%)
EUR 22.04
(-0.27%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 702.53 Million EUR | 0.94% |
| 2022 | 696 Million EUR | 9.78% |
| 2021 | 634.01 Million EUR | 32.11% |
| 2020 | 479.93 Million EUR | 2.77% |
| 2019 | 467.01 Million EUR | 50.17% |
| 2018 | 310.99 Million EUR | -8.61% |
| 2017 | 340.27 Million EUR | -2.47% |
| 2016 | 348.88 Million EUR | 0.45% |
| 2015 | 347.32 Million EUR | 1.38% |
| 2014 | 342.6 Million EUR | 14.37% |
| 2013 | 299.57 Million EUR | 18.05% |
| 2012 | 253.77 Million EUR | 3.26% |
| 2011 | 245.76 Million EUR | 40.8% |
| 2010 | 174.54 Million EUR | 51.7% |
| 2009 | 115.06 Million EUR | 5.86% |
| 2008 | 108.68 Million EUR | 433.04% |
| 2007 | -32.63 Million EUR | -212.69% |
| 2006 | -10.43 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 778.72 Million EUR | 18.83% |
| 2024 Q1 | 655.3 Million EUR | -6.72% |
| 2023 Q2 | 690.72 Million EUR | 7.73% |
| 2023 Q1 | 641.16 Million EUR | -7.88% |
| 2023 FY | 702.53 Million EUR | 0.94% |
| 2023 Q4 | 702.53 Million EUR | 0.87% |
| 2023 Q3 | 696.46 Million EUR | 0.83% |
| 2022 Q1 | 574.53 Million EUR | -9.38% |
| 2022 Q3 | 718.77 Million EUR | 2.44% |
| 2022 Q2 | 701.63 Million EUR | 22.12% |
| 2022 FY | 696 Million EUR | 9.78% |
| 2022 Q4 | 696 Million EUR | -3.17% |
| 2021 Q2 | 587.6 Million EUR | 31.73% |
| 2021 Q1 | 446.07 Million EUR | -7.05% |
| 2021 FY | 634.01 Million EUR | 32.11% |
| 2021 Q3 | 616.62 Million EUR | 4.94% |
| 2021 Q4 | 634.01 Million EUR | 2.82% |
| 2020 FY | 479.93 Million EUR | 2.77% |
| 2020 Q1 | 408.88 Million EUR | -12.45% |
| 2020 Q2 | 104.92 Million EUR | -74.34% |
| 2020 Q3 | 277.15 Million EUR | 164.16% |
| 2020 Q4 | 479.93 Million EUR | 73.16% |
| 2019 Q4 | 467.01 Million EUR | 32.38% |
| 2019 FY | 467.01 Million EUR | 50.17% |
| 2019 Q3 | 352.79 Million EUR | 10.25% |
| 2019 Q1 | 313.82 Million EUR | 0.91% |
| 2019 Q2 | 319.99 Million EUR | 1.97% |
| 2018 Q2 | 287.54 Million EUR | 3.42% |
| 2018 FY | 310.99 Million EUR | -8.61% |
| 2018 Q1 | 278.04 Million EUR | -18.29% |
| 2018 Q4 | 310.99 Million EUR | 6.62% |
| 2018 Q3 | 291.69 Million EUR | 1.44% |
| 2017 Q3 | 315.64 Million EUR | -1.61% |
| 2017 Q2 | 320.8 Million EUR | 4.57% |
| 2017 Q1 | 306.79 Million EUR | -12.06% |
| 2017 FY | 340.27 Million EUR | -2.47% |
| 2017 Q4 | 340.27 Million EUR | 7.8% |
| 2016 Q4 | 348.88 Million EUR | 5.31% |
| 2016 Q1 | 311.43 Million EUR | -10.33% |
| 2016 Q2 | 331.38 Million EUR | 6.4% |
| 2016 FY | 348.88 Million EUR | 0.45% |
| 2016 Q3 | 331.28 Million EUR | -0.03% |
| 2015 Q1 | 316.23 Million EUR | -7.7% |
| 2015 FY | 347.32 Million EUR | 1.38% |
| 2015 Q4 | 347.32 Million EUR | 1.57% |
| 2015 Q3 | 341.95 Million EUR | -0.43% |
| 2015 Q2 | 343.41 Million EUR | 8.6% |
| 2014 Q4 | 342.6 Million EUR | 4.27% |
| 2014 Q3 | 328.58 Million EUR | 4.07% |
| 2014 Q1 | 289.01 Million EUR | -3.52% |
| 2014 Q2 | 315.72 Million EUR | 9.24% |
| 2014 FY | 342.6 Million EUR | 14.37% |
| 2013 Q2 | 240.26 Million EUR | 13.19% |
| 2013 Q3 | 267.77 Million EUR | 11.45% |
| 2013 Q4 | 299.57 Million EUR | 11.87% |
| 2013 FY | 299.57 Million EUR | 18.05% |
| 2013 Q1 | 212.27 Million EUR | -16.35% |
| 2012 Q1 | 218.13 Million EUR | -11.24% |
| 2012 Q3 | 234.22 Million EUR | 1.01% |
| 2012 FY | 253.77 Million EUR | 3.26% |
| 2012 Q4 | 253.77 Million EUR | 8.35% |
| 2012 Q2 | 231.88 Million EUR | 6.3% |
| 2011 Q2 | 241.93 Million EUR | 46.06% |
| 2011 Q3 | 244.28 Million EUR | 0.97% |
| 2011 Q4 | 245.76 Million EUR | 0.6% |
| 2011 FY | 245.76 Million EUR | 40.8% |
| 2011 Q1 | 165.64 Million EUR | -5.1% |
| 2010 Q2 | 112.44 Million EUR | 13.61% |
| 2010 Q3 | 150.09 Million EUR | 33.48% |
| 2010 FY | 174.54 Million EUR | 51.7% |
| 2010 Q4 | 174.54 Million EUR | 16.29% |
| 2010 Q1 | 98.97 Million EUR | -13.98% |
| 2009 Q4 | 115.06 Million EUR | 0.0% |
| 2009 FY | 115.06 Million EUR | 5.86% |
| 2008 FY | 108.68 Million EUR | 433.04% |
| 2007 FY | -32.63 Million EUR | -212.69% |
| 2006 FY | -10.43 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| DocCheck AG | -8.51 Million EUR | 8354.87% |
| MeVis Medical Solutions AG | -7.74 Million EUR | 9172.077% |
| Nexus AG | 2.81 Million EUR | -24892.209% |